353 related articles for article (PubMed ID: 1826418)
1. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status.
Heyes MP; Brew BJ; Martin A; Price RW; Salazar AM; Sidtis JJ; Yergey JA; Mouradian MM; Sadler AE; Keilp J
Ann Neurol; 1991 Feb; 29(2):202-9. PubMed ID: 1826418
[TBL] [Abstract][Full Text] [Related]
2. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.
Heyes MP; Mefford IN; Quearry BJ; Dedhia M; Lackner A
Ann Neurol; 1990 Jun; 27(6):666-75. PubMed ID: 2163238
[TBL] [Abstract][Full Text] [Related]
3. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
Valle M; Price RW; Nilsson A; Heyes M; Verotta D
Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW
Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment.
Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW
AIDS; 1992 May; 6(5):461-5. PubMed ID: 1616651
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical studies on AIDS dementia complex--possible contribution of quinolinic acid during brain damage].
Saito K
Rinsho Byori; 1995 Sep; 43(9):891-901. PubMed ID: 7474452
[TBL] [Abstract][Full Text] [Related]
7. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal reactivity for myelin components precedes development of neurological symptoms in AIDS patients.
Silva AA; Câmara V; Quirico-Santos T
Arch Med Res; 1997; 28(3):391-6. PubMed ID: 9291637
[TBL] [Abstract][Full Text] [Related]
9. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
[TBL] [Abstract][Full Text] [Related]
10. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.
Cinque P; Nebuloni M; Santovito ML; Price RW; Gisslen M; Hagberg L; Bestetti A; Vago G; Lazzarin A; Blasi F; Sidenius N
Ann Neurol; 2004 May; 55(5):687-94. PubMed ID: 15122709
[TBL] [Abstract][Full Text] [Related]
11. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.
Portegies P; Enting RH; de Gans J; Algra PR; Derix MM; Lange JM; Goudsmit J
AIDS; 1993 May; 7(5):669-75. PubMed ID: 8318174
[TBL] [Abstract][Full Text] [Related]
12. A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia.
Rho MB; Wesselingh S; Glass JD; McArthur JC; Choi S; Griffin J; Tyor WR
Brain Behav Immun; 1995 Dec; 9(4):366-77. PubMed ID: 8903853
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.
Burger DM; Boucher CA; Meenhorst PL; Kraayeveld CL; Portegies P; Mulder JW; Hoetelmans RM; Beijnen JH
Antivir Ther; 1997 Apr; 2(2):113-7. PubMed ID: 11322275
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients.
Larsson M; Hagberg L; Forsman A; Norkrans G
J Neurosci Res; 1991 Mar; 28(3):406-9. PubMed ID: 1856886
[TBL] [Abstract][Full Text] [Related]
15. Laboratory evaluations in HIV-1-associated cognitive/motor complex.
Syndulko K; Singer EJ; Nogales-Gaete J; Conrad A; Schmid P; Tourtellotte WW
Psychiatr Clin North Am; 1994 Mar; 17(1):91-123. PubMed ID: 8190671
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome.
Heyes MP; Rubinow D; Lane C; Markey SP
Ann Neurol; 1989 Aug; 26(2):275-7. PubMed ID: 2528321
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy.
Simpson DM
Clin Infect Dis; 1999 Jul; 29(1):19-34. PubMed ID: 10433561
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.
Royal W; Selnes OA; Concha M; Nance-Sproson TE; McArthur JC
Ann Neurol; 1994 Jul; 36(1):32-9. PubMed ID: 7912918
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients.
Sporer B; Koedel U; Popp B; Paul R; Pfister HW
J Neuroimmunol; 2005 Jun; 163(1-2):190-4. PubMed ID: 15885322
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
